<乌鸦传媒>Inotrope Showdown Leaves No Winner in Cardiogenic Shock Long-awaited head-to-head comparison of milrinone and dobutamine Aug 04, 2021
<乌鸦传媒>TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
<乌鸦传媒>Start Rhythm Control Early for Afib With Heart Failure EAST-AFNET 4 trial finds similar benefits across ejection fraction ranges Jul 31, 2021
<乌鸦传媒>SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
<乌鸦传媒>Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
<乌鸦传媒>Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
<乌鸦传媒>Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
<乌鸦传媒>After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
<乌鸦传媒>Scarring on an Otherwise Normal Heart: Reassuring Data Emerge Phenomenon tied to very low burden of major arrhythmic events Jul 14, 2021
<乌鸦传媒>Trouble Looms With Pacemakers After Aortic Valve Replacement Permanent pacemaker implantation of clinical significance in cohort study Jul 13, 2021
<乌鸦传媒>Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
<乌鸦传媒>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<乌鸦传媒>Regenerative Therapy Makes Headway in HF ... in the Right Patients Study of autologous skeletal cell-patch implantation in Japan Jul 02, 2021
<乌鸦传媒>First TTS Case After mRNA Shot; Fake Fellow Strikes Out; Disappearing Pacemaker Recent developments of interest in cardiovascular medicine Jun 29, 2021
<乌鸦传媒>First Close Look at Presumed Myocarditis Cases After COVID Vaccination Case reports suggest a favorable clinical course after hospitalization Jun 17, 2021
<乌鸦传媒>Best MIS-C Treatment? Murky Picture Emerges Large U.S. and international surveillance data series come to conflicting conclusions Jun 16, 2021
<乌鸦传媒>Early Vax Myocarditis Data; Novel RAAS Inhibitor; Star Athletes Collapse Mid-Game Recent developments of interest in cardiovascular medicine Jun 14, 2021
<乌鸦传媒>Op-Ed: Does Your Patient Really Have Diastolic Dysfunction? The Skeptical Cardiologist highlights the confusion in "diastology" Jun 05, 2021
<乌鸦传媒>Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
<乌鸦传媒>Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions A glance at devices coming down the structural heart pipeline in the coming years May 24, 2021
<乌鸦传媒>Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? 30-day data for a new version of the Portico valve May 20, 2021
<乌鸦传媒>Adverse Events Drop With Fuller Accounting of Evolut Low Risk Trial Yet worrying signals with TAVR remain May 19, 2021
<乌鸦传媒>Novel Heart Failure Agent Works Best in Sickest Patients Omecamtiv mecarbil provides benefit to those with low LVEF May 18, 2021
<乌鸦传媒>Entresto Risky for Advanced Heart Failure? LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
<乌鸦传媒>Pacemaker Interference Warning; Religious Fasting and CVD; Toothpick in the Heart Recent developments of interest in cardiovascular medicine May 17, 2021
<乌鸦传媒>Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
<乌鸦传媒>Personalized Rehab Helpful in Heart Failure Patients Trial showed improvements in physical functioning and quality of life compared with usual care May 17, 2021
<乌鸦传媒>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<乌鸦传媒>Mixed Results with ARNI Therapy for Post-MI Heart Failure Prevention Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
<乌鸦传媒>Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy Secondary findings show big gains for more than a third of patients May 15, 2021
<乌鸦传媒>ARNI Therapy in the Hot Seat at Another Virtual ACC PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
<乌鸦传媒>Impressive Disease Control in Metastatic Triple-Negative Breast Cancer ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate May 14, 2021
<乌鸦传媒>COVID Vax & Myocarditis; Ejection Fractions on EKG; Southerners Still Unwell Recent developments of interest in cardiovascular medicine May 10, 2021
<乌鸦传媒>Toxic Cardiology Culture Pervasive Worldwide, ACC Survey Finds No group was immune to hostile work conditions, but women and young doctors got the worst of it May 10, 2021
<乌鸦传媒>Surgical Repair: A Newcomer in Aortic Valve Disease In this podcast, Andrew Perry and Chris Burke tackle the current state of aortic valve repair May 07, 2021 podcast
<乌鸦传媒>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<乌鸦传媒>Farxiga Gets FDA Greenlight for CKD SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks Apr 30, 2021
<乌鸦传媒>Low Radiation Possible During Cardiac Cath in Children NYC center reports encouraging results with ALARA radiation protocol Apr 30, 2021
<乌鸦传媒>Endocarditis After Low-Risk TAVR: Different Trajectory, Problem Organisms Low-risk patients "not immune" to rare infection, LRT studies show Apr 30, 2021
